J. Goldman & CO LP Abeona Therapeutics Inc. Transaction History

J. Goldman & CO LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.07 - $8.68 $1.66 Million - $3.53 Million	-407,066 Reduced 94.71%	22,750 $164,000
Q4 2023 Feb 14, 2024	SELL	$3.71 - $5.14 $243,075 - $336,767	-65,519 Reduced 13.23%	429,816 $2.15 Million
Q3 2023 Nov 14, 2023	SELL	$2.98 - $4.43 $8,072 - $12,000	-2,709 Reduced 0.54%	495,335 $2.09 Million
Q2 2023 Aug 14, 2023	BUY	$2.76 - $5.27 $1.37 Million - $2.62 Million	498,044 New	498,044 $2.01 Million

26.9M

614K

45K

Ticker ABEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,950,380
Market Cap $33.9M
Description
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.